CI Canadian Convertible Bond ETF Common (TSE:CXF - Get Free Report)'s stock price dropped 0.2% during trading on Tuesday . The stock traded as low as C$10.21 and last traded at C$10.21. Approximately 1,479 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 4,494 shares. The stock had previously closed at C$10.23.
CI Canadian Convertible Bond ETF Common Trading Down 0.1%
The stock's fifty day moving average price is C$9.98 and its two-hundred day moving average price is C$10.09.
CI Canadian Convertible Bond ETF Common Company Profile
(
Get Free Report)
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Further Reading
Before you consider CI Canadian Convertible Bond ETF Common, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CI Canadian Convertible Bond ETF Common wasn't on the list.
While CI Canadian Convertible Bond ETF Common currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
